Top 50 Medical VC Funds & Investors in Sweden (November 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Almi Invest
VC Fund
|
29 | Sweden, Norway, United States | Venture - Series Unknown, Seed | Software, Health Care, Manufacturing | $226k–$3.5M |
|
Chalmers Ventures AB
VC Fund
|
14 | Sweden, United States | Pre-Seed, Seed, Venture - Series Unknown | Software, Biotechnology, Information Technology | $5.8k–$3.5M |
|
Sciety
VC Fund
|
10 | Sweden, Ukraine | Seed, Series A, Venture - Series Unknown | Health Care, Biotechnology, Medical | $125k–$6.9M |
|
Hadean Ventures
VC Fund
|
6 | Sweden, Norway, Austria | Series A, Series B, Venture - Series Unknown | Biotechnology, Health Care, Medical | $2M–$79M |
|
SEB Venture Capital
VC Fund
|
6 | Sweden, Denmark, United Kingdom | Series A, Series B | Software, Information Technology, FinTech | $1.5M–$23M |
|
Sweet Studio
VC Fund
|
5 | Sweden | Pre-Seed, Venture - Series Unknown, Seed | iOS, Apps, Audio | $106k–$3.8M |
|
Industrifonden
VC Fund
|
4 | Sweden, United States, Denmark | Series A, Venture - Series Unknown | Biotechnology, Software, Information Technology | $1.6M–$21M |
|
Fåhraeus Startup and Growth
VC Fund
|
4 | Sweden, Denmark, Finland | Seed, Venture - Series Unknown, Series A | Medical, Health Care, Biotechnology | $851k–$7.3M |
|
Index Ventures
VC Fund
|
4 | United States, United Kingdom, Germany | Series A, Series B, Seed | Software, Artificial Intelligence, E-Commerce | $1.3M–$102M |
|
Bonit Capital
VC Fund
|
4 | Sweden, United States, Germany | Seed, Venture - Series Unknown | Health Care, Medical, Apps | $1.1M–$5.1M |
|
Add Health Media
VC Fund
|
4 | Sweden, India | Seed, Venture - Series Unknown | Health Care, Medical, Apps | $251k–$2.6M |
|
Partnerinvest Norr
VC Fund
|
4 | Sweden, United States | Seed, Venture - Series Unknown | Software, Manufacturing, Information Technology | $359k–$4M |
|
Propel Capital
VC Fund
|
4 | Sweden, United States, Norway | Convertible Note, Pre-Seed, Seed | Software, E-Commerce, Health Care | $24k–$615k |
|
Flerie Invest
VC Fund
|
4 | Sweden, United States, United Kingdom | Series A, Series B, Venture - Series Unknown | Biotechnology, Health Care, Pharmaceutical | $2.5M–$75M |
|
Creandum
VC Fund
|
3 | Sweden, United States, Germany | Series A, Seed, Series B | Software, Artificial Intelligence, Information Technology | $1.8M–$80M |
|
Karolinska
VC Fund
|
3 | Sweden, Denmark, United States | Venture - Series Unknown, Seed | Biotechnology, Health Care, Pharmaceutical | $2.1M–$10M |
|
Inventure
VC Fund
|
3 | Finland, Sweden, United States | Seed, Series A, Series B | Software, Information Technology, Artificial Intelligence | $549k–$25M |
|
Crowberry Capital
VC Fund
|
3 | Iceland, Denmark, Finland | Seed, Series A, Pre-Seed | Software, Gaming, Health Care | $400k–$17M |
|
Norrsken VC
VC Fund
|
3 | Sweden, United Kingdom, Germany | Seed, Series A, Venture - Series Unknown | Software, Artificial Intelligence, Health Care | $893k–$156M |
|
Otiva
VC Fund
|
3 | Sweden, France, United Kingdom | Seed, Series A, Venture - Series Unknown | FinTech, E-Commerce, Food and Beverage | $700k–$67M |
|
Scale Capital
VC Fund
|
3 | Denmark, Norway, Germany | Seed, Venture - Series Unknown | Software, Information Technology, Artificial Intelligence | $1M–$14M |
|
Accel
VC Fund
|
2 | United States, India, United Kingdom | Series A, Series B, Seed | Software, Artificial Intelligence, SaaS | $1.3M–$70M |
|
Jovitech Invest
VC Fund
|
2 | Sweden | Seed, Venture - Series Unknown | Solar, Medical, Chemical | $395k–$1M |
|
20 North Street
VC Fund
|
2 | Sweden | Venture - Series Unknown | SaaS, Medical, mHealth | $2.4M–$10M |
|
Nordic Science Investments
VC Fund
|
2 | Finland, Sweden, Germany | Seed, Pre-Seed, Series A | Biotechnology, Medical, Health Diagnostics | $373k–$34M |
|
Dendera Ventures
VC Fund
|
2 | Sweden | Seed, Venture - Series Unknown | Medical, Health Care, News | $430k–$2.2M |
|
Noaber
VC Fund
|
2 | The Netherlands, Israel, Germany | Seed, Series A, Pre-Seed | Health Care, Medical, Fitness | $423k–$20M |
|
Life Science Invest
VC Fund
|
2 | Sweden | Seed, Pre-Seed | Medical, Biotechnology, Biopharma | $310k–$4.6M |
|
3T Invest
VC Fund
|
2 | Sweden, India | Seed, Series A, Angel | Health Care, Medical, Software | $454k–$18M |
|
GU Ventures
VC Fund
|
2 | Sweden, United States | Seed, Pre-Seed, Series A | Health Care, Biotechnology, Pharmaceutical | $658k–$73M |
|
Gunnar Nilsson Cancer Foundation
VC Fund
|
2 | Sweden | Seed, Series A | Medical, Genetics, Biotechnology | |
|
EQT Ventures
VC Fund
|
2 | Sweden, Germany, United States | Series A, Seed, Series B | Software, Artificial Intelligence, Information Technology | $2.5M–$100M |
|
Metsa Spring
VC Fund
|
2 | Finland, Sweden | Seed, Venture - Series Unknown, Series A | GreenTech, Sustainability, Chemical | $395k–$8.3M |
|
GOBIA Enterprises
VC Fund
|
2 | Sweden | Seed, Series A, Venture - Series Unknown | Medical, Health Care, Eyewear | |
|
HealthCap
VC Fund
|
2 | United States, Sweden, France | Series B, Series A | Biotechnology, Health Care, Medical | $6M–$92M |
|
Inbox Capital
VC Fund
|
2 | Sweden, Finland, United States | Venture - Series Unknown, Series A, Seed | Software, Apps, SaaS | $1.2M–$20M |
|
KTH Holding
VC Fund
|
2 | Sweden, Germany, United Kingdom | Venture - Series Unknown, Pre-Seed, Seed | Software, Information Technology, Health Care | $23k–$5.5M |
|
Novo Holdings
VC Fund
|
2 | United States, Denmark, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $9.5M–$135M |
|
Heartcore Capital
VC Fund
|
2 | United States, Denmark, Germany | Seed, Series A, Series B | Software, Artificial Intelligence, E-Commerce | $1.3M–$58M |
|
Sting Capital
VC Fund
|
2 | Sweden | Seed, Pre-Seed | Software, Apps, Medical | $216k–$776k |
|
LU Ventures
VC Fund
|
2 | Sweden | Venture - Series Unknown, Pre-Seed | Medical, SaaS, Software | $336k–$1.6M |
|
Project A Ventures
VC Fund
|
2 | Germany, United Kingdom, United States | Seed, Series A, Series B | Software, Artificial Intelligence, E-Commerce | $1.3M–$75M |
|
Uppsala universitet Invest AB
VC Fund
|
2 | Sweden | Seed | Medical, Health Diagnostics, CleanTech | $727k–$1.8M |
|
Sweet Capital
VC Fund
|
2 | United States, United Kingdom, Sweden | Seed, Series A, Venture - Series Unknown | Apps, Software, Mobile | $443k–$45M |
|
Faro Capital
VC Fund
|
1 | Sweden, United States | Series A, Seed | Biotechnology, Gaming, Medical | |
|
Ferd
VC Fund
|
1 | Norway, Sweden, United States | Private Equity, Series A | Software, Energy, Information Technology | $2.2M–$14M |
|
Teknoinvest
VC Fund
|
1 | Sweden, Norway, United States | Series B, Series A | Health Care, Biotechnology, Medical | $1.2M–$31M |
|
Bonnier Capital
VC Fund
|
1 | Sweden, Finland, Germany | Seed, Series A | Internet, Software, E-Commerce | $1M–$21M |
|
Nordic Foodtech VC
VC Fund
|
1 | Finland, Sweden, Denmark | Seed, Series A | Biotechnology, Life Science, Water | |
|
Tham Invest
VC Fund
|
1 | Sweden | Pre-Seed | Medical, Wellness, Health Care | |
| Access all 243 VC funds in Sweden Medical startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Almi Invest is Sweden’s most active early-stage venture capital firm, investing in scalable startups across Sustainability, Industry, Tech, and Life Science. We invest from pre-seed to Series A, always co-investing with independent private investors to accelerate innovation and long-term success. Our portfolio spans sustainable solutions, industrial innovation, deep tech, SaaS, and life science, supporting startups that drive economic and environmental progress. With €430 million under management and over 1,000 investments since 2009, we have backed leading companies like MIPS, Tobii, and Neo4j, with notable exits to Google, Apple, Microsoft, and Qlik. Beyond capital, we offer engaged ownership, providing strategic guidance, active board participation, and access to an extensive investor network. Almi Invest is part of the Almi Group and is funded by the European Regional Development Fund, Almi AB, and regional partners.
Show more...Investment focus
- Industry: Software, Health Care, Manufacturing
- Stage:Venture - Series Unknown, Seed
- Geography: Sweden, Norway, United States
Investor stats
- Total investments: 600
- Round size: Seed $226k–$2.2M; Venture - Series Unknown $338k–$3.5M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — raised $64M in 2024
Portfolio highlights
- Ambidex AB — helps food retailers create new revenue streams on their refrigeration systems by stabilizing the electricity grid.
- Indevex AB — Indevex is a science-based and privately owned biotech company from Sweden. A natural and reliable partner, providing evidence based natural nutrition concepts based on the patented NGC™ Formula.
- Xaga Surgical — Xaga Surgical aims to minimize the risk of infections by inventing safer medical needles.
We are a leading tech investor & venture builder in the Nordics. Taking deep tech from lab to market.WELCOMEINVESTMENTS
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Pre-Seed, Seed, Venture - Series Unknown
- Geography: Sweden, United States
Investor stats
- Total investments: 283
- Round size: Seed $237k–$2.5M; Pre-Seed $5.8k–$349k; Venture - Series Unknown $357k–$3.5M
- Lead/follow: 45% lead, 55% follow
Portfolio highlights
- Ambidex AB — helps food retailers create new revenue streams on their refrigeration systems by stabilizing the electricity grid.
- Solinide Photonics — Solinide Photonics is a technological company spun out of Chalmers University of Technology. It develops ultra-efficient silicon nitride-based photonic circuits and microcomb technologies.
- InfiniNode Technologies AB — InfiniNode is a semiconductor IP company that seeks to enable efficient data movement in future compute systems.
Whether you are an investor or entrepreneur, partner with Sciety to achieve impactful returns and elevate your life science business in the Nordics.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Sweden, Ukraine
Investor stats
- Total investments: 47
- Round size: Seed $125k–$2.3M; Series A $457k–$6.5M; Venture - Series Unknown $1.6M–$6.9M
- Lead/follow: 91% lead, 9% follow
Portfolio highlights
- NEOGAP Therapeutics — NEOGAP Therapeutics is a clinical-stage biopharmaceutical startup focused on immuno oncology. Their pharmaceutical product, personalized tumor trained lymphocytes, offers even one customized cell treatment that is meant to precisely target and destroy cancer in a tailored environment, with very minor side effects.
- Everdrone — Advanced drone operations for public safety and emergency response
- Single Technologies — SINGLE TECHNOLOGIES develops a new type of single-molecule-sensitive 3D sequencing system.They provide single-molecule detection, fiber optics, 3D imaging, genomics, sequencing, and 3-D Seq.
Hadean Ventures is a life science fund manager that invests in life science companies across europe with a particular focus on the nordic region. The funds are backed by leading private and institutional investors. Hadean Ventures has offices in oslo and stockholm and collaborates with world-class academic institutions and start-up hubs across the region
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: Sweden, Norway, Austria
Investor stats
- Total investments: 36
- Round size: Series A $4.2M–$79M; Series B $4.5M–$75M; Venture - Series Unknown $2M–$29M
- Lead/follow: 50% lead, 50% follow
- Last fund: May invest from a new fund soon — raised $168M in 2021
Portfolio highlights
- Oncoinvent — Oncoinvent AS designs and develops cancer treatments by applying known physical and chemical principles of selected novel materials in new ways in order to maximize their medical benefit while minimizing potential safety concerns.
- Kasvu Therapeutics — Kasvu develops first and best-in-class small molecule neuroplastogens for diseases where neuronal connectivity is altered
- TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
SEB Venture Capital is a Fintech investor that helps entrepreneurs and innovators launch and grow profitable businesses. They primarily serve as a strategic corporate venture focused on Fintech investments, with the option of partnering with SEB. They are also on the hunt for game-changing inventive solutions to new technologies that will make the financial industry smarter, safer, and more environmentally responsible, as well as more user-friendly. They also function as an evergreen fund, giving them the flexibility and staying strength to focus on long-term wealth development depending on what is best for the firm and its shareholders.
Show more...Investment focus
- Industry: Software, Information Technology, FinTech
- Stage:Series A, Series B
- Geography: Sweden, Denmark, United Kingdom
Investor stats
- Total investments: 78
- Round size: Series A $1.5M–$7.4M; Series B $2.2M–$23M
- Lead/follow: 45% lead, 55% follow
- Last fund: May invest from a new fund soon — raised $300M in 1995
Portfolio highlights
- Apica — Apica provides the most effective technology for optimizing the performance of cloud and mobile applications. The Apica WebExcellence Suite offers companies and developers alike easy-to-use, cloud-based load testing and web performance monitoring tools to test applications for maximum capacity, daily performance, improved load times, and protectionfrom peak load.
- MobileTag — Mobile Tag, the European leader in mobile barcode solutions, continues to innovate with the launch of its latest application: mobiletag Universal Reader and shopping.Mobile Tag is behind the creation of the flashcode, the standard 2D barcode used by operators in France. This type of Datamatrix barcode is used by the biggest companies indisplay, transportation, distribution, the pharmaceutical industry, and more.Mobile Tag has always tried to develop new technology from the consumer's point of view, and the mobiletag Universal Reader & shopping is no exception.The concept behind this application is to send, receive and share information and best prices to everyone and for everyone through all standardized barcodes.Scanning a barcode with your mobile phone is simply taking a picture of it with your phone, using the mobiletag application. Mobile tag is free!
- CorPower Ocean — CorPower Ocean AB was founded in 2009 to develop high efficiency Wave Energy Converters (WECs).CorPower's Wave Energy Converters deliver five times higher annual energy output per ton of device compared to previously known wave power solutions. The step-change improvement in performance and efficiency allows a Cost-of-Energy that cancompete with offshore wind. The products are currently in pilot with Iberdrola. CorPower has assembled a team with extensive experience in energy generation, design and manufacturing of production equipment, system engineering as well as the market expertise to allow us to continue transforming the technology of tomorrow into renewable energy applications of today.
We co-found companies, dedicating our in-house team of designers, developers, and marketers to bring ideas to life. With every venture we co-found, our mission is to advance the consumer experience across industries with world-class technology, data-informed design, and lots of heart. Are you an entrepreneur who shares our mission?
Show more...Investment focus
- Industry: iOS, Apps, Audio
- Stage:Pre-Seed, Venture - Series Unknown, Seed
- Geography: Sweden
Investor stats
- Total investments: 7
- Round size: Pre-Seed $172k–$400k; Venture - Series Unknown $106k–$3.8M
- Lead/follow: 57% lead, 43% follow
Portfolio highlights
- Koo! — Koo! is an audio based social networking service that let users record and listen to 1-minute audio clips called Koos.
- Alex Therapeutics — The Alex DTx Platform enables partners within pharma and health care to effectively and reliably launch new DTx treatments by leveraging existing insights, modules, processes and data.
- Stride Leadership — Stride is the revolutionary leadership product built to help become a confident leader. For too long, we’ve been taught that leadership is an elite act that’s linked to your job title. Now you hold leadership development in your hand, regardless of your age, job title, or seniority.With Stride, you’ll learn what it truly means to lead, and how todo it. We’ll bust common myths and you’ll discover which style of leadership is the best fit for you. Designed by leadership and design experts, Stride will help you learn the mindset required, the basics of leadership, and techniques for dealing with inevitable challenges. Whether you’re new to leadership or you’re a seasoned professional you’ll love learning and forming new habits with Stride.
Industrifonden is a Nordic evergreen venture capital firm with a fund size of $600m, that focuses on early-stage technology and life science companies with international potential. The company works long term with the entrepreneurs we invest in, and have a strong track record of building game changing companies. Industrifonden-backed companies include tech companies Qlik, Arcam, Soundtrack Your Brand, Fishbrain, and life science companies CellaVision, Oncopeptides and AMRA.
Show more...Investment focus
- Industry: Biotechnology, Software, Information Technology
- Stage:Series A, Venture - Series Unknown
- Geography: Sweden, United States, Denmark
Investor stats
- Total investments: 205
- Round size: Series A $3.3M–$21M; Venture - Series Unknown $1.6M–$20M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Avtal24 — Avtal24 offers in an easily accessible manner agreements for both private individuals and companies. They believe in making the law available to everyone and they want everyone to have access to legal security. With us, you write agreements online or together with a lawyer by phone. Always at a fixed price. With high legal expertise, innovativetechnology and great focus on customer benefit and offer the market's most accessible legal services.Avtal24 was founded in 2004 and is headquartered in Stockholm, Sweden.
- Fibbl — Enhance your e-commerce store with high-quality 3D product visualization for footwear. Scale 3D, AR, and virtual try-on experiences to boost engagement and conversions.
- Trackpaw Scientific — Stress-free 24/7 home-cage monitoring of weight, activity and behaviour for every animal, without handling and without blind spots.
FSG (Fåhraeus Startup and Growth) is a Lund-based venture capital firm investing at the intersection of life science and tech, including digital health, medtech, diagnostics and life science tools. It invests €1–6M per company from Seed to Series A, selectively Series B.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Sweden, Denmark, Finland
Investor stats
- Total investments: 14
- Round size: Seed $851k–$2.7M; Series A $1.8M–$5.9M; Venture - Series Unknown $1.1M–$7.3M
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- Aplagon — Aplagon is committed to bringing unique, effective antithrombotic medicines with important safety advantages to patients with unmet needs.
- Fida Biosystems — Quantification and characterisation of complex biology made simple. Study molecular interactions in solution, with only nanoliters of sample. Used by industry leaders.
- Trackpaw Scientific — Stress-free 24/7 home-cage monitoring of weight, activity and behaviour for every animal, without handling and without blind spots.
Index Ventures is an international venture capital firm with dual headquarters in San Francisco and London, investing in technology-enabled companies with a focus on e-commerce, fintech, mobility, gaming, infrastructure/AI, and security.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, E-Commerce
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 1635
- Round size: Seed $1.3M–$16M; Series A $5M–$35M; Series B $12M–$102M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely actively investing — fresh fund, raised $400M in 2026
Portfolio highlights
- PanGenetics — PanGenetics B.V. develops monoclonal antibodies for the treatment of immune mediated diseases.PanGenetics is a clinical development company that specializes in taking antibodies from the late research stage through to clinical proof of concept. The company is based in Utrecht, the Netherlands with an office in Cambridge, UK. PanGenetics employsa lean business model with manufacturing and clinical development activities outsourced to specialist providers. Apart from PG110, the other clinical program of PanGenetics is PG102, a CD40 antagonist for treatment of autoimmune diseases which is currently being evaluated in a clinical study in psoriatic arthritis patients
- Acutus Medical — Acutus Medical develops medical technologies to treat complex cardiac arrhythmia. The company's platform displays the heart’s true activation pattern, turning the chaos of a complex arrhythmia into a clear vision for electrophysiologists.Acutus Medical is a privately funded company founded in 2011 and based in Carlsbad, California. Itsproducts are co-developed in the U.S. and Europe with an exceptional team of medical scientists, biomedical engineers, and other professionals.It was founded in 2011 and headquartered in Carlsbad, California.
- Milestone Systems — See and know more with video technology. Milestone offers award-winning XProtect video management software, Arcules VSaaS, and BriefCam analytics.
Bonit Capital is a Swedish family-owned investment company. We invest across sectors and asset classes, including social investments and outcome models.Venture Capital - We invest in ambitious founders within the life science sector. We take an active ownership approach by providing capital, industry expertise and access to an internationalnetwork. Our focus areas are digital health, medical technology and diagnostics.Private Equity - We invest in entrepreneurial teams with deep sector expertise and unique market access, primarily in the lower to mid-market buyout segment, with the aim to produce superior returns and meaningful portfolio diversification.Listed Equity - Our strategy is to obtain a broad market exposure through mainly external mandates, and to seek superior returns in individual shares primarily in life science. Among Bonit's main holdings are the world-leading medtech company Elekta AB, founded by Laurent Leksell.Leksell Social Ventures - LSV is the first impact investor in Sweden with a focus on outcome models and direct investments in the areas of mental health, education and social integration. Striving for systemic change, LSV contributes to social innovation and societal development by giving social entrepreneurs and social ideas the necessary prerequisites to develop and progress – through financing, idea development and networking with private, public and nonprofit actors.
Show more...Investment focus
- Industry: Health Care, Medical, Apps
- Stage:Seed, Venture - Series Unknown
- Geography: Sweden, United States, Germany
Investor stats
- Total investments: 13
- Round size: Seed $1.8M–$4.2M; Venture - Series Unknown $1.1M–$5.1M
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- Vården.se — Vården.se is Sweden's largest private search service in healthcare and health .
- Bentley — Bentley engages in the development, manufacturing for minimal-invasive treatments of vascular diseases.
- Alex Therapeutics — The Alex DTx Platform enables partners within pharma and health care to effectively and reliably launch new DTx treatments by leveraging existing insights, modules, processes and data.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Add Health Media is a company that specializes in creating marketing materials for health companies.
Show more...Investment focus
- Industry: Health Care, Medical, Apps
- Stage:Seed, Venture - Series Unknown
- Geography: Sweden, India
Investor stats
- Total investments: 19
- Round size: Seed $251k–$2.6M; Venture - Series Unknown $320k–$1.1M
- Lead/follow: 37% lead, 63% follow
Portfolio highlights
- Eatit — Eatit is a digital therapeutics platform for obesity treatment by dietitians.
- Dropmed — Dropmed is a Stockholm-based startup aiming to digitally transform medical device sales by providing groundbreaking tools for E-Commerce enablement and guided purchasing.
- Migränhjälpen — Migränhjälpen is providing digital health services.
Partnerinvest Norr is a private equity firm specialized in software, security, and biometrics sectors. Partnerinvest Övre Norrland AB is a venture capital firms that seeks to invest in limited companies which have are in the expansion phase.
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Seed, Venture - Series Unknown
- Geography: Sweden, United States
Investor stats
- Total investments: 70
- Round size: Seed $554k–$2.2M; Venture - Series Unknown $359k–$4M
- Lead/follow: 16% lead, 84% follow
- Last fund: May invest from a new fund soon — raised $32M in 2009
Portfolio highlights
- Cold River Games — Crystalfall is an upcoming free online action RPG with customizable skills and an endless endgame, set in a steampunk world.
- Original Creation — Original Creation envisions a sustainable future in which capital is focused on long-term benefits for both people and the environment, and resources are properly managed through circular systems."
- Remos Space Systems — Remos Space Systems simplifies satellite ground operations.
Founded in 2014, Propel Capital has invested in over 170+ Sting startups. Offering generous investments to early-stage tech companies.
Show more...Investment focus
- Industry: Software, E-Commerce, Health Care
- Stage:Convertible Note, Pre-Seed, Seed
- Geography: Sweden, United States, Norway
Investor stats
- Total investments: 173
- Round size: Seed $24k–$615k; Pre-Seed $34k–$580k; Convertible Note $34k–$55k
- Lead/follow: 7% lead, 93% follow
- Last fund: Likely still investing — raised $3M in 2022
Portfolio highlights
- Mother — Mother is a deep-tech mental health company that aims to fill the niche between conventional health services and self-help approaches.
- Seaqure Labs AB — Seaqure Labs is a biotech startup utilizing mycoproteins as the solution for current unsustainable methods within aquaculture. Grounded in the fundamental principles of the circular economy, the technology empowers us to manufacture sustainable, economically viable ingredients, great for the planet and great for fish.
- Freya Industries — Freya Industries builds the intelligence layer for physical security: connected sensors and the platform that turns what they capture into actionable insights
Flerie is an active long-term life science investor, focusing on biotech and pharmaceutical investments globally.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: Sweden, United States, United Kingdom
Investor stats
- Total investments: 30
- Round size: Series A $2.5M–$21M; Series B $12M–$75M; Venture - Series Unknown $4.5M–$47M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- AnaCardio — AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility and aims to improve clinical outcomes in heart failure.
- Nanologica — Nanologica combines unique know-how in the field of materials technology with a genuine interest in solving real problems in life science. The company works with nanoporous silica which has properties that are attractive in a wide variety of applications. In order to succeed, development work is carried out in close dialog with customers.Nanologica is unique in that it is a world leader in controlling the form, type of porosity and surface area of particles of silica. This competence can be used to produce particles that have the potential to solve problems in diverse application areas. The company’s core competency has been developed and expanded in twoareas of application in particular: drug delivery on the one hand and on the other chromatography, a technology used for the separation and purification of products on the market and in development.The starting point for Nanologica’s work is the material sciences, a field in which the company’s founder has developed and patented completely new materials. The initial research was based at Stockholm University and the Ångström laboratories atUppsala University.
- Microbiotica — Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers. The company's therapeutics identify gut bacteria linked to phenotype with unprecedented precision, enabling researchers to phenotype before testing of candidate bacteria in advanced human in vitro and invivo models.
We support early-stage founders in building global, category-defining companies. From Seed to IPO and beyond.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Series A, Seed, Series B
- Geography: Sweden, United States, Germany
Investor stats
- Total investments: 334
- Round size: Seed $1.8M–$19M; Series A $5.2M–$31M; Series B $10M–$80M
- Lead/follow: 38% lead, 62% follow
- Last fund: Likely still investing — raised $545M in 2024
Portfolio highlights
- Atlas Bio — Atlas Bio is a biotechnology company that develops a predictive foundation AI model of human biology.
- MACHENTA — Machenta develops artificial intelligence and robotics software focused on instant learning for robots. The company builds systems that enable robotic platforms to learn manipulation and control tasks rapidly, reducing the need for extensive manual programming or long training cycles. Its software is used to help automated machines adapt to diverse environments and handle complex physical interaction workflows. Machenta operates in robotics and AI software as well as broader information technology services and experimental research on natural sciences and engineering. Its work targets organizations that deploy or develop robotic systems and require advanced learning capabilities integrated into their hardware and infrastructure.
- Ares Intelligence — Ares Intelligence conducts automated internal interviews across a company's workforce to analyze operational inefficiencies and identify where the business can integrate artificial intelligence effectively.
Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. The business model is to: SELECT the most commercially attractive medical innovations; DEVELOP innovations to the stage where the greatest return on investment can be achieved; and COMMERCIALIZE the innovations through the sale of companies or out-licensing of products. Karolinska Development has developed a well-structured selection process to identify the most commercially attractive medical innovations screened by KIAB. Pharmaceutical development is a high-risk enterprise. In most cases, development projects fail because of side effects or insufficient efficacy. Successful selection of innovations is fundamental to Karolinska Development’s business model, which makes the inflow of new projects crucial. One key to success lies in selecting those innovations that can be developed from scientific findings to products and have significant commercial potential. To date, over 1,300 projects have been screened by KIAB. The portfolio companies are often founded together with the innovators and are initially operated as virtual companies with few or no employees. During the first six to twelve months, the companies normally have minimal fixed costs and technological development is outsourced. The innovator, who is often employed at an academic institution, normally participates as a board member and scientific advisor. The CEO of a portfolio company cooperates closely with a representative of Karolinska Development, who in most cases is also a board member of the company. The companies are capitalized to reach their next milestone, usually within a period of six to eighteen months. Development projects are continuously monitored, and those that do not meet their stipulated targets are discontinued. In the first three to four years, a portfolio company’s operating expenses are often limited to a few million Swedish kronor per year, which cover the cost of external studies and the salary of the staff. In subsequent years, Karolinska Development and other investors play an important role recruiting key expertise to the companies Karolinska Development intends to realize value by exiting portfolio companies or through out-licensing of projects. Such transactions (especially out-licensing) are often structured as single upfront payments followed by payments based on predetermined milestones and royalties on sales. Although Karolinska Development has a flexible exit strategy, pharmaceutical products are, for two reasons, preferably exited at Phase II. First a successful Phase II study indicates that the pharmaceutical has an effect on patients, which is an important value-enhancing factor when negotiating out-licensing or sales. Secondly, finalizing product development and undertaking Phase III clinical trials frequently requires very large patient populations. In many cases this requires much greater resources than those available at Karolinska Development but these can be found in established pharmaceutical companies. Several licensing deals were closed in 2011 involving projects with a similar focus and development phase to Karolinska Development's projects.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Venture - Series Unknown, Seed
- Geography: Sweden, Denmark, United States
Investor stats
- Total investments: 32
- Round size: Venture - Series Unknown $2.1M–$10M
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- BOOST Pharma — BOOST Pharma is developing BT-101, an off-the-shelf therapy for early intervention in children with severe osteogenesis imperfecta (OI).
- Modus Therapeutics — Modus Therapeutics is a Swedish drug development company developing sevuparin – a novel drug to treat people suffering from Sickle Cell Disease – a painful, inherited blood disorder affecting millions of people around the globe.
- Umecrine Cognition — Umecrine Cognition is a Swedish clinical-stage pharmaceutical company developing a novel class of drugs to treat neurological disorders of the brain.
Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: Finland, Sweden, United States
Investor stats
- Total investments: 180
- Round size: Seed $549k–$6M; Series A $1.3M–$17M; Series B $1.3M–$25M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely still investing — raised $140M in 2022
Portfolio highlights
- Lassie — Lassie is the first proactive and preventive pet insurance company that wants to help pet owners take better care of their pets
- Capalo AI — We maximize the value of your energy storage systems. Now and in the future.
- Algorithmiq — Algorithmiq utilizes its expertise in quantum information, complex systems, and computational physics to develop algorithms to develop new and effective drugs, solve problems in life sciences, and discover new materials.
Crowberry Capital invests at seed and early stage in emerging technology ventures in the Nordics. Our mission is to back people that are good for companies and build companies that are good for people. We have a strong follow-through philosophy and commit to putting your company first.
Show more...Investment focus
- Industry: Software, Gaming, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Iceland, Denmark, Finland
Investor stats
- Total investments: 52
- Round size: Seed $1.6M–$4.4M; Pre-Seed $400k–$1.3M; Series A $5.7M–$17M
- Lead/follow: 46% lead, 54% follow
- Last fund: May invest from a new fund soon — raised $90M in 2021
Portfolio highlights
- Quanscient — Quanscient develops multiphysics simulation software utilizing quantum computing algorithms to improve simulation technology. Its Computer Aided Engineering (CAE) platform integrates a unique combination of cloud-native multiphysics solvers, advanced cloud computing, and future quantum integration. The platform also offers engineers over ahundredfold increase in simulation throughput to enable fully digital R&D processes, addressing complex technology challenges in industries like fusion energy, 6G/7G, advanced semiconductors, biomedical, automotive, and aerospace.
- SNERPA Power — SNERPA Power develops intelligent energy services.
- Augmented Hearing — Read more about danish audiology scale-up Augmented Hearing, driving the world's most ambitious audiology solutions and innovations.
We are a venture capital fund investigating in Start-Ups solving the worlds biggest problems while building massive businesses.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Sweden, United Kingdom, Germany
Investor stats
- Total investments: 110
- Round size: Seed $893k–$14M; Series A $4.4M–$52M; Venture - Series Unknown $1.1M–$156M
- Lead/follow: 32% lead, 68% follow
- Last fund: Likely still investing — raised $346M in 2024
Portfolio highlights
- Biorce — Meet the world's first AI clinical trials assistant! We bring innovative technologies to revolutionize healthcare and drug development faster & more efficiently
- Endra — Endra is a purpose-built platform for modern MEP engineering. Generate 3D models and drawings, sync with Revit and enjoy coordinated design workflows.
- Sava Technology — SAVA is reinventing health monitoring with a novel biosensing platform enabling real-time, affordable, and painless molecular monitoring.
Equity investment company doing Series A to late growth, private and public. Agile and long-term with no fixed holding period.
Show more...Investment focus
- Industry: FinTech, E-Commerce, Food and Beverage
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Sweden, France, United Kingdom
Investor stats
- Total investments: 20
- Round size: Seed $700k–$3.2M; Series A $3.9M–$12M; Venture - Series Unknown $2.6M–$67M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- AllPlants — AllPlants operates as UK's vegan meal delivery service. All their packaging is 100% recyclable, partly compostable, and mostly reusable. They’re creating delicious dinners to inspire more plant-based living, so people + planet thrive together. To start that journey, They’re delivering their hand-prepared meals to doorsteps UK-wide.
- BlaBlaCar — BlaBlaCar is the world’s leading long-distance carpooling community, connecting people looking to travel long distances with drivers going the same way. They travel together and share the costs of the journey. The platform is engineered to create a secure, trust-based community with declared identities and full member profiles. Members can evenspecify how chatty they are from “Bla” to “BlaBlaBla”, hence the name BlaBlaCar. BlaBlaCar is creating a global people-powered network with a trusted community of drivers and passengers.Backed by Accel Partners, Insight Ventures, Index Ventures, Lead Edge Capital, Baring Vostok and ISAI, it operates in 22 countries across Europe, Russia, Turkey, Mexico, Brazil and India. The site and free mobile apps provide a range of features to create a secure, trust-based community and easy connections between drivers and passengers.BlaBlaCar is based in Paris with offices across a dozen of countries.
- Pet Media Group — Woof Woof. Europe's Largest Pet Marketplaces PetMediaGroup is the leading operator of online marketplaces for pets and related goods and services. Through our trusted and local brands, we help thousands of animals every day to find a new loving home as well as assist their human caregivers
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Scale Capital is an early-stage technology investor, helping Nordic, B2B, and tech founder teams scale and win in the US market.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Venture - Series Unknown
- Geography: Denmark, Norway, Germany
Investor stats
- Total investments: 30
- Round size: Seed $1M–$14M; Venture - Series Unknown $1.4M–$6.1M
- Lead/follow: 53% lead, 47% follow
- Last fund: Likely still investing — raised $60M in 2022
Portfolio highlights
- Sonair — Sonair is building ADAR, the world's first safety-certified 3D sensor for human-robot collaboration. The commercial product is available now. Reach out for a demo.
- Pandektes — Search, verify, and rely on the law. Pandektes vast database combined with industry-leading search means more firepower in every legal analysis.
- INLEAP Photonics — INLEAP Photonics develops ultra-fast, high-precision laser system technology for secure drone defence and highly efficient industrial processes.
First partner to exceptional teams everywhere
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Series A, Series B, Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 2569
- Round size: Seed $1.3M–$11M; Series A $4.4M–$41M; Series B $9.3M–$70M
- Lead/follow: 44% lead, 56% follow
- Last fund: Likely actively investing — fresh fund, raised $750M in 2026
Portfolio highlights
- MobStac — Developer of a cloud-based mobile marketing platform designed to connect the digital and physical worlds through the use of innovative technology. The company's platform is based on the principals of proximity marketing and engage customers in a personalized, context-aware way that leverages indoor location and proximity, enabling businessesand brands to leverage BLE beacon technology to deliver context-rich experiences to their end users.
- Krux — Use Salesforce's data management platform (DMP) to unify your data and strengthen customer relationships across every touchpoint.
- Perplexity — Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence.
Jovitech Invest help entrepreneur-led companies to grow profitably through active, long-term ownership
Show more...Investment focus
- Industry: Solar, Medical, Chemical
- Stage:Seed, Venture - Series Unknown
- Geography: Sweden
Investor stats
- Total investments: 4
- Round size: Seed $395k–$1M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Adsorbi — Adsorbi use cellulose from the Nordic forest to help air purification companies to capture gaseous air pollutants.
- EnginZyme — Enzymatic chemistry for cleaner ingredients in personal care, food and pharma. Enginzyme's patented EziG platform makes enzymes work at industrial scale.
- Mat4Green Tech — Mat4Green Tech develops a technology that recycles Indium from industrial waste in an efficient and climate-neutral way.
20 North Street is the name HDR Partners uses when adding investors and industrial experience to small growth companies.
Show more...Investment focus
- Industry: SaaS, Medical, mHealth
- Stage:Venture - Series Unknown
- Geography: Sweden
Investor stats
- Total investments: 3
- Round size: Venture - Series Unknown $2.4M–$10M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Innspire — Innspire, founded on 2012 by Martin Chevalley, developed a software solution enabling guests to connect their own devices to the hotels' technology system.
- Coala Life — Coala Life is a Swedish medical technology and life science company that focuses on heart diagnostics and digital health. The company has developed a portfolio of solutions based on the Coala, a patented and commercial service for remote monitoring and self-screening of heart sounds and ECG. The Coala is available direct to consumers and theCoala Pro is offered to healthcare professionals to enable smart, digital cardiac assessments.
We partner with founders to transform unseen scientific discoveries into future breakthroughs, jointly moving businesses, people, and the world forward.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Diagnostics
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland, Sweden, Germany
Investor stats
- Total investments: 19
- Round size: Seed $373k–$4.6M; Pre-Seed $380k–$837k; Series A $2.9M–$34M
- Lead/follow: 79% lead, 21% follow
- Last fund: Likely still investing — raised $34M in 2024
Portfolio highlights
- MuRay — MuRay develops non-destructive 3D inspection technology powered by an artificial muon beam that is generated on demand via a compact laser-plasma accelerator. The startup's value proposition centers on replacing slow cosmic muon tracking with an active, rapid accelerator platform that yields 100x deeper material penetration than conventional X-rays. Its technology enables high-resolution, internal structural analysis of massive, high-density elements across industrial aerospace, automated security, and medical imaging applications.
- mu-ray.tech — MuRay Tech generates a controlled muon beam to image inside solid metal and 3D printed pieces. Non-destructively. In minutes.
- Kasvu Therapeutics — Kasvu develops first and best-in-class small molecule neuroplastogens for diseases where neuronal connectivity is altered
Just another WordPress site
Show more...Investment focus
- Industry: Medical, Health Care, News
- Stage:Seed, Venture - Series Unknown
- Geography: Sweden
Investor stats
- Total investments: 3
- Round size: Seed $430k–$2.2M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Ifrågasätt — Ifrågasätt is a startup based in Malmö, Sweden, that will become the media world’s #1 supplier of traffic, loyalty and user engagement. Working together with customers, Ifrågasätt offers cost-efficient products to help news sites regain and keep readers and increase their engagement, while building reader loyalty.Ifrågasätt’s first product,launched in Sweden August 2017, is a commenting service that is easily implemented on the customers’ — the newspapers — own sites. The commenting service consists of not only a technical commenting solution, but also manual AI/ML-supported 24/7 moderation, traffic-increasing activities, as well as user verification and user management.In less then a year, Ifrågasätt has gained a lot of publicity and traction and has already signed multiple customers, including Sweden’s largest daily newspaper (Dagens Nyheter), Sweden’s largest regional newspaper (Göteborgs-Posten) and the Nordics’ largest business journal (Dagens industri).
- Joint Academy — Deliver better virtual care, lower costs, uncover new insights, and grow your business with Joint Academy.
- Learning To Sleep — Learning To Sleep offers clinically proven sleep improvement programs for people with sleep disorder through web and mobile devices. Their products has already helped over 40 000 people to live a better life and their unique business model establish also a strong relation between patients and their physicist.
Noaber Ventures invests in initiatives that bring social transformations using information technology.
Show more...Investment focus
- Industry: Health Care, Medical, Fitness
- Stage:Seed, Series A, Pre-Seed
- Geography: The Netherlands, Israel, Germany
Investor stats
- Total investments: 20
- Round size: Seed $423k–$6.3M; Series A $3M–$20M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Plasmacure — Plasmacure develops innovative plasma technology for wound care. Discover how cold plasma is transforming the treatment of chronic wounds.
- Mirantus Health — Mirantus is building a distributed healthcare provider to improve access to care for underserved patients. Through healthcare services (Mirantus Care) and cloud-solutions (Mirantus OS), Mirantus empowers doctors to efficiently treat patients who were difficult to reach before. This improves healthcare access for patients, allows physicians to earnmore, while saving payors billions in downstream costs. Mirantus is on a mission to get every specialist physician in Europe to participate in distributed healthcare, to improve healthcare access for 100M+ underserved patients.
- Alba Health — Discover your baby's gut health & microbiome for the best start in life.
LSI Academy - New education February 2027, read more here
Show more...Investment focus
- Industry: Medical, Biotechnology, Biopharma
- Stage:Seed, Pre-Seed
- Geography: Sweden
Investor stats
- Total investments: 6
- Round size: Seed $682k–$4.6M; Pre-Seed $310k–$500k
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Haga Bioscience — Mission Technology Assays Benefits Team Contact us Focus whereit truly matters. In situ RNA detection at single nucleotide resolution, bridging discovery and translation. Our mission Bridging discovery and translation Spatial omics technologies have transformed how we study tissue biology.However, translating these discoveries into robust, actionable biomarkers remains a major bottleneck, limited by a lack of
- CubaseBio — Cubase Bio is developing optics-free DNA microscopy to map gene expression in 3D through intact organoids and tissue. Based in Stockholm.
- SampleFacts — Next generation Dried Blood Spot sampling – separating cells and plasma at the point of collection.
3T Invest started an interesting and fulfilling journey back in 2009. From the beginning they focused on the establishment of sustainable Venture Capital, supporting innovation and entrepreneurship. they are always committed to backing outstanding entrepreneurs with the necessary resources.
Show more...Investment focus
- Industry: Health Care, Medical, Software
- Stage:Seed, Series A, Angel
- Geography: Sweden, India
Investor stats
- Total investments: 12
- Round size: Seed $454k–$18M; Series A $3.9M–$6.5M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- NEOGAP Therapeutics — NEOGAP Therapeutics is a clinical-stage biopharmaceutical startup focused on immuno oncology. Their pharmaceutical product, personalized tumor trained lymphocytes, offers even one customized cell treatment that is meant to precisely target and destroy cancer in a tailored environment, with very minor side effects.
- Predicare — Predicare develops a decision support system for healthcare called RETTS. RETTS' fast emergency triage and treatment system works by measuring and assessing vital parameters at the first examination, as well as by gathering a structured and standardized medical history regarding the reason for the visit and the patient’s current symptoms.Predicare was founded in 2011 and is headquartered in Gothenburg, Sweden.
- Warp News — Fact-based optimistic news and ideas on technology, science and human progress. Formerly Warp News. Click to read The Angry Optimist, a Substack publication with thousands of subscribers.
GU Ventures build businesses out of groundbreaking ideas that help shape a better tomorrow. Our passionate team of company builders, financial experts, IP and legal talent ensure success for our companies.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Pharmaceutical
- Stage:Seed, Pre-Seed, Series A
- Geography: Sweden, United States
Investor stats
- Total investments: 12
- Round size: Seed $658k–$5.6M; Pre-Seed $717k–$1.4M; Series A $2.3M–$73M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- OlsAro — OlsAro produces salt-tolerant crops.
- NSS Water — NSS Water specializes in innovative water purification technology for high-tech sectors such as semiconductors.
- Aventix — Aventix is a bioanalytics/life-science instrumentation company that develops sensor-based laboratory tools.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Gunnar Nilsson Cancer Foundation
Show more...Investment focus
- Industry: Medical, Genetics, Biotechnology
- Stage:Seed, Series A
- Geography: Sweden
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- SAGA Diagnostics — SAGA Diagnostics AB is a personalized cancer diagnostics and disease monitoring company focused on molecular genetic analyses of a powerful cancer biomarker: circulating tumor DNA (ctDNA). The company was founded in 2016 as a spin-out from a highly successful research group at Lund University, with a mission to improve precision cancer medicine,provide more accurate treatment monitoring, and improve patient survival using minimally-invasive liquid biopsy cancer testing services and kits.The SAGA team consists of renowned scientists, highly qualified staff and an experienced management team who work together to launch SAGA’s ultrasensitive services and products as part of the ongoing revolution in cancer research, drug development, and clinical diagnostics. SAGA’s proprietary tests can help patients, oncologists, and drug developers detect actionable mutations, stratify patient groups, and monitor treatment response, residual disease, and disease recurrence at an unprecedented sensitivity.
EQT Ventures is a European VC fund with just over €2.3 billion in total capital raised. EQT Ventures I launched in May 2016, with commitments totaling €566 million and a simple mission - to be the kind of VC the team would have liked to have had on their own startup journeys. Recognizing that building and growing a company takes more than just capital, the EQT Ventures team provides founders with support and advice throughout different stages of growth. EQT Ventures doesn't focus on particular markets or industries, but on bold and ambitious founders who have the grit and determination to build global success stories. EQT Ventures II launched in November 2019, with commitments totaling €660 million. EQT Ventures III launched in 2022, with commitments totaling €1.1 billion, making it the biggest European Venture Capital fund committed to early-stage tech startups. The EQT Ventures team is based across six offices in London, Stockholm, Berlin, Paris, Amsterdam, Paris, and San Francisco, taking a locals-with-locals approach and supporting founders on the ground. Motherbrain, EQT Ventures' in-house-developed artificial intelligence (AI) platform, ensures the team has a data-driven approach and has driven more than $100 million in portfolio company investments.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Series A, Seed, Series B
- Geography: Sweden, Germany, United States
Investor stats
- Total investments: 304
- Round size: Seed $2.5M–$14M; Series A $6M–$44M; Series B $15M–$100M
- Lead/follow: 55% lead, 45% follow
- Last fund: Likely still investing — raised $1.1B in 2022
Portfolio highlights
- Biolevate — Elevate human : Accelerating life sciences, empowering people
- Nevis — AI that helps financial advisors grow and spend more time with clients
- Flow Engineering — Flow is the agentic systems engineering platform for the companies building the physical world. Next-gen hardware teams use Flow as their default platform to design, build, and iterate on hardware faster without sacrificing engineering rigor. Today, thousands of engineers at companies including Rivian, Stoke Space, Joby, Astranis, and Radiant are building on Flow. Flow gives these teams a living system of record that connects requirements, CAD, simulation, code, and test. On top of this system of record, Flow's agents continuously analyze engineering changes, identify downstream impact, and verify requirements and test coverage — so work stays aligned across the tools engineers already use.
We boldly invest in and support promising startups and potential innovations that explore new uses for sustainably-grown Nordic wood.
Show more...Investment focus
- Industry: GreenTech, Sustainability, Chemical
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Finland, Sweden
Investor stats
- Total investments: 12
- Round size: Seed $395k–$5.9M; Series A $4.4M–$8.3M
- Lead/follow: 58% lead, 42% follow
Portfolio highlights
- Adsorbi — Adsorbi use cellulose from the Nordic forest to help air purification companies to capture gaseous air pollutants.
- FineCell — FineCell is a sustainable cellulose microfibers provider that enables manufacturers to make new products with reduced carbon footprints and differentiated properties.The company's cellulose microfibers possess physical and chemical properties that differ from competing products and provide differentiated benefits for the users. It has beensupported by Vinnova (Sweden’s innovation agency) and EIT InnoEnergy.The Linköping, Ostergotlands Lan-based company was established in 2015 by Jonatan Henschen, Jonas Engstrand, Monica Ek, and Kloce Dongfang Li.
- Fiberwood — Fiberwood is a new eco-friendly wood fiber insulation that can be used for a variety of purposes. Fiberwood has excellent insulating properties, is entirely bio-based, and thus contains no plastic or other fossil-based materials.
GOBIA Enterprises is owned by Jan G Smith who has been active in the pharmaceutical industry.
Show more...Investment focus
- Industry: Medical, Health Care, Eyewear
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Sweden
Investor stats
- Total investments: 3
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Njord Medtech — Njord develops Medtech products to help improve productivity at hospitals.
- Profundus Imaging — Profundus' retinal imaging technology enables researchers and clinicians in particular to visualise subclinical changes of retinal disease.
- Thioredoxin Systems — TXN Systems is developing a new approach to antibacterial therapy by targeting bacterial thioredoxin reductase and disrupting essential redox defence systems.
HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A
- Geography: United States, Sweden, France
Investor stats
- Total investments: 141
- Round size: Series A $6M–$73M; Series B $12M–$92M
- Lead/follow: 26% lead, 74% follow
- Last fund: Likely still investing — raised $179M in 2024
Portfolio highlights
- Neobiomics — Neobiomics is a Swedish life-science company that develops nutritional products for preterm infants and neonatal care. Its best-known products include ProPrems® and NeoMega36®.
- AMRA Medical — AMRA Medical is a digital health company transforming medical research and clinical care using rapid whole-body MRI technology.
- Ultragenyx Pharmaceutical — Ultragenyx is focused on developing first-ever approved treatments for rare and ultrarare diseases and moving the rare disease community forward.
Inbox Capital is a privately held investment company based in Stockholm, mainly focusing on disruptive and fast growing tech companies.
Show more...Investment focus
- Industry: Software, Apps, SaaS
- Stage:Venture - Series Unknown, Series A, Seed
- Geography: Sweden, Finland, United States
Investor stats
- Total investments: 48
- Round size: Seed $1.2M–$5.9M; Series A $2.1M–$11M; Venture - Series Unknown $1.4M–$20M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- Billogram — Since its start in 2011, Billogram has revitalized the outdated invoicing process by offering companies with recurring payments an intelligent digital platform. Using smart technology, we help companies strengthen their customer relations while also automating payment processes in a way that lowers costs, increases revenue, and reduces churn. Theresult is a payment that pays off for everyone.
- Carla — Carla creates the most convenient, transparent, and simple online platform for purchasing or leasing an electric car.
- Fast Travel Games — Fast Travel Games is a VR exclusive game developer and publisher, founded by industry leading veterans and behind acclaimed titles such as Apex Construct and Wraith: The Oblivion - Afterlife.
KTH Holding is a state-owned limited company managed by KTH's University Board. It invests in promising startup companies that are based on research or teaching at KTH, with the aim of supporting commercialization and making it easier for new science to benefit society.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Venture - Series Unknown, Pre-Seed, Seed
- Geography: Sweden, Germany, United Kingdom
Investor stats
- Total investments: 54
- Round size: Seed $55k–$5.5M; Pre-Seed $23k–$27k; Venture - Series Unknown $1.1M–$1.6M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- Cellfion — Cellfion provides sustainable materials for next level clean energy storage and conversion devices.
- porkchop — In-space logistics for SmallSats in Low Earth Orbit and beyond.
- Novatron — A new fusion reactor design for stable plasma confinement and fusion power generation.
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Denmark, United Kingdom
Investor stats
- Total investments: 415
- Round size: Series A $9.5M–$133M; Series B $15M–$135M; Series C $35M–$118M
- Lead/follow: 40% lead, 60% follow
- Last fund: May invest from a new fund soon — raised $165M in 2018
Portfolio highlights
- Windward Bio — Windward Bio is a clinical-stage, drug development company committed to improving outcomes for people living with serious immunological diseases.
- SCHOTT Poonawalla — SCHOTT Poonawalla is a manufacturer of pharmaceutical containers, made of neutral glass tubing. The company provides parenteral packaging systems crafted from tubular glass, serving the pharmaceutical industry with a broad range of products including vials, pre-fillable syringes, ampoules, and cartridges.
- Vantia Therapeutics — Vantia Therapeutics is an emerging pharmaceutical company developing novel, small molecule drugs targeting large areas of unmet medical need. Its strong clinical pipeline includes VA106483 for nocturia and VA111913 for dysmenorrhoea, which directly target indications that together affect many millions of people, are poorly treated and representbillion dollar markets. Vantia's strategy is to develop its proprietary drug candidates through Phase II clinical testing and then commercialise through partnerships. The Company was founded in 2008 and is backed by specialist life science investors Novo A/S, SV Life Sciences and MVM Life Science Partners.
Heartcore Capital invests in companies re-enchanting the world through technology.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, E-Commerce
- Stage:Seed, Series A, Series B
- Geography: United States, Denmark, Germany
Investor stats
- Total investments: 223
- Round size: Seed $1.3M–$11M; Series A $3.4M–$27M; Series B $9.5M–$58M
- Lead/follow: 28% lead, 72% follow
- Last fund: Likely actively investing — fresh fund, raised $179M in 2024
Portfolio highlights
- Fora — Fora's expert travel advisors will help you plan your dream trip while unlocking exclusive perks and upgrades. Welcome to the modern travel agency.
- Nous — Find out exactly how your household finances will be affected by the cost-of-living crisis with Nous on your side.
- PhaseTree — Materials design simulation company - PhaseTree ApS
Sting – Stockholm Innovation & Growth enables talented people to turn their ideas into sustainable businesses. The support they offer includes qualified coaching in business development, a business angel network, a venture capital fund, a recruitment service, and an international network of investors, business contacts and experts. Itcontribute to the success of Sweden’s future technology companies by helping them to grow and compete internationally.
Show more...Investment focus
- Industry: Software, Apps, Medical
- Stage:Seed, Pre-Seed
- Geography: Sweden
Investor stats
- Total investments: 16
- Round size: Seed $216k–$776k; Pre-Seed $412k–$611k
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Prion — Prion makes it quick and easy for the preschool staff to give parents insight into what happens at preschool - together with the children. The app is available free for iPhone, Android and iPad.
- Texelio — Texelio a company who is set to redefine financial market news by developing AI which empowers the customers of Retail banks, Online Brokers and Investment Service platforms.
- Minnemera — Minnemera develops digital neurocognitive tests.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!LU Ventures, part of Lund University Innovation, co-founds spin-off companies with university researchers to commercialize research and drive global impact. It supports academics in building companies while allowing them to stay in academia, funding IP costs, recruiting CEOs/CTOs and board experts, and establishing legal/financialframeworks to attract external capit
Show more...Investment focus
- Industry: Medical, SaaS, Software
- Stage:Venture - Series Unknown, Pre-Seed
- Geography: Sweden
Investor stats
- Total investments: 3
- Round size: Venture - Series Unknown $336k–$1.6M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Waveium — Waveium develops a cloud-based SaaS platform that provides instant wireless design simulations and validation for engineers and wireless developers. The platform enables users to test and optimize wireless systems in real time using scalable, automated simulations. It exposes functionality through an API so teams can integrate wireless performancetesting into network planning, product development workflows, and AI training pipelines. Waveium focuses on reducing the time and cost of traditional measurement-based wireless validation while supporting experimentation with new wireless features.
- Cyclicor — Cyclicor is an innovations based company focused on the development and commercialisation of safer and more sustainable polymers. The company was registered in October of 2012 as a spin-off company from the University of Lund in Sweden and began commercial development of its first product Cycli-ClearTM, a bisphenol free polycarbonate, in late 2013.
- Aventera Antibodies — Developing a First-in-Class Therapy for Invasive Group A Streptococcal Infections.
Project A is an early-stage venture capital firm, combining financial and operational support for technology companies. In addition to $1bn in assets under management, Project A provides its portfolio companies with a wide range of operational support services. This includes more than 100 experts from key areas such as software engineering, business intelligence, marketing, and recruiting. The portfolio includes companies such as Trade Republic, sennder, KRY, Catawiki, WorldRemit, Spryker, and Voi.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, E-Commerce
- Stage:Seed, Series A, Series B
- Geography: Germany, United Kingdom, United States
Investor stats
- Total investments: 239
- Round size: Seed $1.3M–$8.9M; Series A $3.8M–$28M; Series B $6.2M–$75M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely actively investing — fresh fund, raised $377M in 2025
Portfolio highlights
- Nexcade — Nexcade AI agents run freight quoting, tenders, rates, bookings, and reporting with your team, visible and controlled at every step.
- Project Q — European defence integration. Deployed with Bundeswehr, validated at NATO. Open-core, ITAR-free, no vendor lock-in. Connect sensors to C2 in seconds.
- Nettle — The AI workspace for Loss Control
Uppsala universitet Invest AB focuses on investment management, particularly in early-stage ventures. The company collaborates with researchers and students, providing financial support and strategic guidance for innovative projects. It aims for long-term investment horizons, typically ranging from 5 to 15 years. Uppsala universitet Invest AB alsopartners with other investors and co-financiers to support research-driven initiatives.
Show more...Investment focus
- Industry: Medical, Health Diagnostics, CleanTech
- Stage:Seed
- Geography: Sweden
Investor stats
- Total investments: 3
- Round size: Seed $727k–$1.8M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Caplyzer — The world's first supercapacitive electrolyzer, membrane-free and built for renewable power.
- SampleFacts — Next generation Dried Blood Spot sampling – separating cells and plasma at the point of collection.
- Readily Diagnostics — Readily Diagnostics develops speedy and accurate diagnostic tests for respiratory disorders, enabling faster and more effective therapy at the point of care.
Sweet Capital is the private investment fund of the founders of King.com (Candy Crush Saga), following their $5.9b sale to Activision Blizzard in 2015 (ATVI:US; acq. MSFT:US).
Show more...Investment focus
- Industry: Apps, Software, Mobile
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: United States, United Kingdom, Sweden
Investor stats
- Total investments: 70
- Round size: Seed $1.8M–$5M; Series A $3M–$32M; Venture - Series Unknown $443k–$45M
- Lead/follow: 24% lead, 76% follow
Portfolio highlights
- Pachama — Harnessing AI to drive carbon capture and protect global forests
- The Expert — Book consultations with the world's top design experts
- Alex Therapeutics — The Alex DTx Platform enables partners within pharma and health care to effectively and reliably launch new DTx treatments by leveraging existing insights, modules, processes and data.
FARO is an Argentina company over 10 years of experience in the development and operation of integrated projects in the agribusiness sector. All projects FARO own position it as a reference and leader both locally and internationally.Among his various projects, FARO operates the largest tree planting pecan nut Latin America, with projection tobecome the largest southern hemisphere and one of the largest in the world. This project is structured under different vehicles, including Alto Pecan stands, the first real estate development of nautical fields planted with pecan nut Latin America, located in Villa Paranacito, Entre Ríos . Another project is AgroConsortium, productive trust for the production and marketing of cereals and oilseeds in leased farms located in different productive areas in Argentina and potentially in the region. Finally, thanks to the expertise acquired in agribusiness, FARO developed his own business model for productive land conversion. Its aim is to position rural properties whose productive potential is not reflected in the price and complement the cycle with the economic use of land in intensive production, short and medium term.Since 2006, the Investor Group is a strategic partner OMBU FARO for all investment portfolios development ventures related to agribusiness, that focus on supply both local and international markets.
Show more...Investment focus
- Industry: Biotechnology, Gaming, Medical
- Stage:Series A, Seed
- Geography: Sweden, United States
Investor stats
- Total investments: 5
- Lead/follow: no public data
Portfolio highlights
- Bionamic — Bionamic provides solutions for the analysis of life science data to reduce or eliminate the manual steps between raw data and results.
- Bluwhale — Unlock Web3 Wallet Potential with AI Insights. Supercharge Your Business Growth
- IntuiCell — IntuiCell develops a fundamentally new recursive computing architecture and associated technology platform.
Ferd er et familieeid investeringsselskap som er eid av femte og sjette generasjon Andresen.
Show more...Investment focus
- Industry: Software, Energy, Information Technology
- Stage:Private Equity, Series A
- Geography: Norway, Sweden, United States
Investor stats
- Total investments: 59
- Round size: Series A $2.2M–$13M; Private Equity $13M–$14M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — last raise in 2005
Portfolio highlights
- wheel.me — The first and only autonomous wheel in the world. The innovation transforms anything into an autonomous mobile robot with minimal effort and without the need to alter its design or form. The company was founded in 2013 and is headquartered in Oslo, Norway.
- Nofence — Manage your livestock from anywhere with GPS collars and a simple app. Unlock more acres, cut fencing costs, and run your operation on your terms.
- Kvist Solutions — Kvist Solutions tilbyr programvare som forenkler BREEAM sertifisering. Vi gir deg oversikt over hele prosjektet, slik at veien til sertifisering blir oversiktlig og forutsigbar.
Teknoinvest is a premier Scandinavian venture capital company. They invest in areas of emerging technologies within the ITC and Life Sciences sectors. Their main geographical scope is Scandinavia and the USA. Teknoinvest was established as the first venture capital investment company. Teknoinvest is one of the most successful VC´s in Scandinaviaaccording to track record of value created for their investors.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series A
- Geography: Sweden, Norway, United States
Investor stats
- Total investments: 25
- Round size: Series A $1.2M–$12M; Series B $6M–$31M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- GLO — glō is a venture-backed company focused on the development and commercialization of advanced LED display products using nanotechnology. The unique nanotechnology is based on 11 years of research at Lund University’s Nanometer Structure Consortium. Headed by Professor Lars Samuelson, one of the world’s leading scientists in this field, who haspublished more than 500 papers related to this technology.glō's first office is in Lund, Sweden, where basic material research continues for the next generation nanotechnology. glō's research and product development along with pilot fabrication operation is carried out at glō-USA in Sunnyvale, California. In 2016, glō established an Asia office in Taipei, Taiwan, one of the largest and fastest-growing regions for LED lighting and display applications.glō's technology sidesteps the technical limitations of current planar LED technology. It allows for the creation of highly efficient, stable and ultimately unique red, green, blue (RGB) emitters out of one material system. It aims to achieve the industry’s best color stability and ultimately enables the growth of red, green and blue emitters on the same wafer. Highly-efficient white LEDs with high color rendering will be possible without the need for phosphor conversion. It is the next enabling technology for advanced display, illumination and automotive applications.glō nanowire light-emitting diodes (nLEDs) are based on its proprietary hetero-structured semiconductor nanowire epitaxial growth and process technologies for which standard manufacturing equipment and materials can be utilized.glō currently holds over 175 patents across US, Europe and Asia. These patents are not subject to any cross-licensing with the LED oligopoly. The glō team is constantly strengthening its intellectual property position in this technology and related applications.
- SantoSolve — SantoSolve is developing topical analgesic products based on non-radioactive strontium as the active substance. The Development program was initiated based on experimental clinical use of strontium-based products showing evidence of strong local analgesic effects on several localized pain conditions of both nociceptive and neuropatic origin. Nosignificant adverse effects associated with the treatment was reported.The company’s lead product, 2PX, is topically administered, utilizing dermal penetration enhancers for delivery of the active agent to its subdermal site of action. Phase I safety and pharmacology studies showed the active agent to have low systemic bioavailability, and only few and minor adverse effects were observed at the site of administration. In open label Phase II clinical trials, the product has shown strong analgesic effect in both nociceptive and neuropatic pain conditions. In follow up, placebo controlled trials, the analgesic effect of the product has been further documented. In the company’s most advanced pain indication under study, osteoarthritis, the company has recently completed the Phase II program.These trials supports the open label results and document statistically that the analgesic effect in patients treated with 2PX is superior to that observed with placebo treatment.
- Sol Voltaics — Founded in 2007, Sol Voltaics AB is a venture-backed, development-stage nanotechnology company focused on development and commercialization of highly efficient, third-generation photovoltaic concentrator solar cells based on its proprietary heterostructured nanowire epitaxial growth and process technologies.
Bonnier Capital is the investment division of the Bonnier Group. Since 2016, we invest in promising companies in structurally growing industries and have become a reliant investment partner to companies of various sizes.
Show more...Investment focus
- Industry: Internet, Software, E-Commerce
- Stage:Seed, Series A
- Geography: Sweden, Finland, Germany
Investor stats
- Total investments: 59
- Round size: Seed $1M–$5.9M; Series A $3.4M–$21M
- Lead/follow: 39% lead, 61% follow
Portfolio highlights
- Acast — Want to start a podcast? Acast can help. We're the world's leading independent podcast company, helping creators and advertisers reach listeners globally.
- AAC Clyde Space —
- Mediaflow Europe — Mediaflow Europe is a SaaS company that provides its platform for image, video, design, templates, and document sharing and management.
We are investing in #FutureFood. Nordic FoodTech VC is the first fund in the Nordics investing explicitly in the future of food
Show more...Investment focus
- Industry: Biotechnology, Life Science, Water
- Stage:Seed, Series A
- Geography: Finland, Sweden, Denmark
Investor stats
- Total investments: 26
- Lead/follow: no public data
Portfolio highlights
- EvodiaBio — Mirroring nature with pioneering bioscience for natural flavors
- Endless Food — Endless Food Co is a food innovation firm focusing on the junction of pleasure and sustainability. Endless Food Co was pulled together by a common idea that the transition to a greener and more egalitarian future food system will be driven by flavor, and having spent the last decade pioneering sustainable gastronomy
- Happy Plant Protein — Revolutionize plant protein production with Happy Plant Protein's innovative technology, transforming local ingredients into high-quality, sustainable solutions for the food industry.
Tham Invest is an investment firm.
Show more...Investment focus
- Industry: Medical, Wellness, Health Care
- Stage:Pre-Seed
- Geography: Sweden
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Letterlife — Letterlife is a unique tool and community designed to empower and support females with ADHD.The platform offers a range of resources and support, including coaching, online courses, and a community forum where women can connect with others who share similar experiences. Through Letterlife, women with ADHD can learn strategies to manage theirsymptoms, gain confidence, and build a strong sense of community.
Medical VC funding in Sweden at a glance
Stats across 336 deals from 243 investors.
Access all 243 VC funds in Sweden Medical startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical VC Funds in Sweden investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 243 VC funds investing in Sweden Medical startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!